Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11.53 | 10.94 | 9.11 | 9.91 | 9.77 | 11.24 | 12.13 | 9.64 | 11.23 | 12.86 | 9.89 | 10.62 |
| Expenses | 6.01 | 5.67 | 6.33 | 6.48 | 7.36 | 7.37 | 7.66 | 7.18 | 8.94 | 8.59 | 9.72 | 9.76 |
| Operating Profit | 5.52 | 5.27 | 2.78 | 3.43 | 2.41 | 3.87 | 4.47 | 2.46 | 2.29 | 4.27 | 0.17 | 0.86 |
| OPM % | 47.88% | 48.17% | 30.52% | 34.61% | 24.67% | 34.43% | 36.85% | 25.52% | 20.39% | 33.20% | 1.72% | 8.10% |
| Other Income | 0.19 | 0.28 | 0.33 | 0.34 | 1.69 | 1.00 | 0.44 | 0.59 | 0.75 | 0.12 | 0.65 | 0.44 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 1.81 | 1.74 | 1.73 | 1.73 | 1.75 | 1.76 | 1.73 | 1.77 | 1.78 | 1.80 | 1.76 | 1.90 |
| Profit before tax | 3.90 | 3.81 | 1.38 | 2.04 | 2.35 | 3.11 | 3.18 | 1.28 | 1.26 | 2.59 | -0.94 | -0.60 |
| Tax % | 27.18% | 11.55% | 51.45% | 37.25% | 42.55% | 45.66% | 61.32% | 22.66% | 165.87% | 25.48% | 235.11% | -25.00% |
| Net Profit | 2.83 | 3.36 | 0.66 | 1.29 | 1.35 | 1.69 | 1.23 | 0.99 | -0.84 | 1.93 | -3.15 | -0.46 |
| EPS in Rs | 0.46 | 0.55 | 0.11 | 0.21 | 0.22 | 0.28 | 0.20 | 0.16 | -0.14 | 0.32 | -0.52 | -0.08 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.06 | 2.25 | 11.14 | 13.03 | 26.02 | 22.45 | 36.57 | 42.42 | 40.83 | 43.05 | 43.61 | 44.60 |
| Expenses | 9.73 | 12.65 | 19.01 | 16.54 | 17.04 | 16.07 | 19.11 | 21.71 | 23.56 | 28.87 | 34.42 | 37.01 |
| Operating Profit | -7.67 | -10.40 | -7.87 | -3.51 | 8.98 | 6.38 | 17.46 | 20.71 | 17.27 | 14.18 | 9.19 | 7.59 |
| OPM % | -372.33% | -462.22% | -70.65% | -26.94% | 34.51% | 28.42% | 47.74% | 48.82% | 42.30% | 32.94% | 21.07% | 17.02% |
| Other Income | 0.04 | 1.91 | 2.37 | 4.71 | 7.54 | 0.41 | 0.63 | 1.08 | 0.96 | 3.47 | 2.11 | 1.96 |
| Interest | 7.55 | 7.50 | 2.45 | 0.12 | 0.89 | 1.55 | 1.22 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 3.96 | 3.87 | 3.90 | 4.20 | 4.85 | 6.46 | 6.97 | 7.17 | 7.09 | 6.96 | 7.11 | 7.24 |
| Profit before tax | -19.14 | -19.86 | -11.85 | -3.12 | 10.78 | -1.22 | 9.90 | 14.51 | 11.14 | 10.69 | 4.19 | 2.31 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -123.94% | 20.12% | 25.49% | 47.52% | 125.54% | |
| Net Profit | -19.14 | -19.87 | -11.85 | -3.13 | 10.78 | -1.22 | 22.18 | 11.59 | 8.30 | 5.61 | -1.07 | -2.52 |
| EPS in Rs | -3.14 | -3.26 | -1.94 | -0.51 | 1.77 | -0.20 | 3.63 | 1.90 | 1.36 | 0.92 | -0.18 | -0.42 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 36% | 14% | 1% | 4% | ||
| Compounded Profit Growth | 7% | 2% | % | -150% | ||
| Stock Price CAGR | 2% | -2% | -8% | -17% | ||
| Return on Equity | % | 11% | 4% | -1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 34.43 | 34.43 | 34.43 | 61.03 | 61.03 | 61.03 | 61.03 | 61.03 | 61.03 | 61.03 | 61.03 | 61.03 |
| Reserves | -61.68 | -80.49 | -100.33 | -19.01 | -22.13 | -11.40 | -12.62 | 9.61 | 21.24 | 29.51 | 35.10 | 34.09 |
| Borrowings | 54.32 | 54.29 | 54.28 | 0.00 | 20.24 | 21.42 | 20.66 | 6.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 36.64 | 44.69 | 62.37 | 39.72 | 25.45 | 14.51 | 16.78 | 17.45 | 18.61 | 15.66 | 14.70 | 16.04 |
| Total Liabilities | 63.71 | 52.92 | 50.75 | 81.74 | 84.59 | 85.56 | 85.85 | 94.09 | 100.88 | 106.20 | 110.83 | 111.16 |
| Fixed Assets | 52.13 | 48.17 | 46.83 | 44.43 | 43.11 | 48.73 | 74.23 | 70.91 | 65.38 | 65.58 | 60.87 | 62.29 |
| CWIP | 0.00 | 0.00 | 0.00 | 2.32 | 16.95 | 29.08 | 2.18 | 0.28 | 4.98 | 1.96 | 3.57 | 3.60 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 11.58 | 4.75 | 3.92 | 34.99 | 24.53 | 7.75 | 9.44 | 22.90 | 30.52 | 38.66 | 46.39 | 45.27 |
| Total Assets | 63.71 | 52.92 | 50.75 | 81.74 | 84.59 | 85.56 | 85.85 | 94.09 | 100.88 | 106.20 | 110.83 | 111.16 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -7.72 | -4.80 | 1.64 | -16.25 | -14.04 | 11.38 | 5.74 | 17.67 | 20.66 | 11.82 | 9.54 | 10.20 |
| Cash from Investing Activity | 0.34 | 5.50 | -0.69 | -2.65 | -16.19 | -20.79 | -4.82 | -1.84 | -5.82 | -21.15 | 15.21 | -6.49 |
| Cash from Financing Activity | 6.77 | -0.83 | -0.72 | 46.83 | 15.02 | -2.70 | 0.45 | -15.87 | -6.11 | 0.00 | 0.00 | 0.00 |
| Net Cash Flow | -0.60 | -0.13 | 0.23 | 27.92 | -15.21 | -12.11 | 1.38 | -0.04 | 8.73 | -9.33 | 24.76 | 3.71 |
| Free Cash Flow | -7.75 | -4.81 | 0.93 | -20.07 | -32.07 | -10.37 | 0.83 | 15.73 | 14.47 | 7.59 | 5.62 | 1.88 |
| CFO/OP | 38% | 76% | -15% | 203% | 387% | 130% | 92% | 107% | 106% | 75% | 81% | 105% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 35.78 | 62.01 | 0.00 | 0.00 | 66.11 | 26.09 | 61.78 | 39.22 | 28.57 | 29.05 | 63.16 | 73.49 |
| Inventory Days | 232.69 | 305.45 | 202.29 | 374.12 | 294.03 | |||||||
| Days Payable | 222.42 | 816.45 | 1,127.98 | 2,468.31 | 2,088.61 | |||||||
| Cash Conversion Cycle | 46.05 | -448.99 | -925.69 | -2,094.19 | -1,728.47 | 26.09 | 61.78 | 39.22 | 28.57 | 29.05 | 63.16 | 73.49 |
| Working Capital Days | -7,875.23 | -17,133.74 | -18,700.98 | -1,218.52 | -1,103.96 | -432.75 | -163.56 | -106.00 | -98.86 | -62.93 | -27.98 | -12.05 |
| ROCE % | -61.54% | -65.67% | -61.84% | -5.93% | 8.14% | 0.47% | 15.26% | 18.35% | 12.94% | 9.40% | 4.59% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 68.84% | 68.84% | 68.84% | 68.84% | 68.84% | 68.84% | 68.84% | 68.84% | 68.84% | 68.84% | 68.84% | 68.84% |
| DIIs | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Government | 0.98% | 0.98% | 0.98% | 0.98% | 0.98% | 0.98% | 0.98% | 0.98% | 0.98% | 0.98% | 0.98% | 0.98% |
| Public | 30.17% | 30.17% | 30.17% | 30.16% | 30.18% | 30.18% | 30.18% | 30.17% | 30.18% | 30.18% | 30.17% | 30.17% |
| No. of Shareholders | 9,589 | 9,762 | 9,819 | 9,750 | 10,641 | 10,667 | 10,690 | 10,661 | 10,670 | 10,464 | 10,301 | 10,161 |
Fundamentals
Market Cap₹ 259 Cr.
Current Price₹ 42.5
Book Value₹ 15.6
ROCE4.59 %
ROE-1.15 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)4%
Compounded Profit Growth (TTM)-150%
Standalone figures.
Valuation
Market capRs 256 Cr
Enterprise valueRs 226 Cr
Price to book2.69x
Price to sales5.75x
EV / EBITDA23.65x
EV / EBIT97.77x
EV / sales5.06x
Price to cash flow25.12x
Earnings yield-0.98%
P/E, 3-year average49.97x
P/B, 3-year average3.16x
P/E, 5-year average34.65x
P/B, 5-year average3.46x
Profitability
Operating margin (excl. other income)21.07%
Operating margin (incl. other income)25.91%
EBITDA margin21.41%
Pre-tax margin5.18%
Net profit margin-5.65%
Net margin, latest quarter-4.33%
ROE-1.12%
ROCE4.38%
ROA-0.96%
ROE, 3-year average4.83%
ROCE, 3-year average9.58%
ROA, 3-year average4.07%
ROE, 5-year average13.38%
ROCE, 5-year average12.48%
ROA, 5-year average9.75%
ROIC (approx.)-0.91%
Tax rate125.54%
Other income / net worth2.22%
Growth
Sales growth (latest year)1.30%
Profit growth (latest year)-119.07%
Sales CAGR, 3 years0.93%
Sales CAGR, 5 years14.20%
Sales growth QoQ7.38%
Sales growth YoY (latest quarter)10.17%
Profit growth YoY (latest quarter)-146.46%
Per share
EPS (TTM)Rs -0.41
EPS (latest year)Rs -0.18
EPS (latest quarter)Rs -0.08
EPS, 3-year averageRs 0.70
EPS, 5-year averageRs 1.53
Book value per shareRs 15.59
Sales per shareRs 7.31
Cash flow per shareRs 1.67
Free cash flow per shareRs 0.31
Efficiency
Asset turnover0.39x
Fixed asset turnover0.70x
Debtor days73 days
Debtors turnover4.97x
Creditor days2089 days
Cash conversion cycle73 days
Working capital days-12 days
Leverage
Cash and bankRs 30 Cr
Net debtRs -30 Cr
Net debt / EBITDA-3.19x
Owners' fund to total sources85.57%
Cash flow
Cash from Operating Activity (latest year)Rs 10 Cr
Cash from Investing Activity (latest year)Rs -6 Cr
Net Cash Flow (latest year)Rs 4 Cr
Free cash flow (latest year)Rs 2 Cr
Cash from ops / profit, 5 years1.50x
Sales to cash flow4.28x
Statement figures
Net sales (TTM)Rs 45 Cr
Net sales (latest year)Rs 44 Cr
Sales (latest quarter)Rs 11 Cr
Operating profit excl. other income (latest year)Rs 9 Cr
Operating profit (latest quarter)Rs 1 Cr
Other income (TTM)Rs 2 Cr
EBITDA (TTM)Rs 10 Cr
PBDT (TTM)Rs 10 Cr
Profit before tax (TTM)Rs 2 Cr
Tax (latest year)Rs 5 Cr
Net profit (TTM)Rs -3 Cr
Net profit (latest year)Rs -1 Cr
Net profit (latest quarter)Rs -0 Cr
Depreciation (TTM)Rs 7 Cr
Depreciation (latest quarter)Rs 2 Cr
Cost of goods sold (latest year)Rs 15 Cr
Total expenditure (latest year)Rs 34 Cr
Total income (latest year)Rs 46 Cr
Share capitalRs 61 Cr
ReservesRs 34 Cr
Shareholders' fundsRs 95 Cr
Total assetsRs 111 Cr
Net blockRs 62 Cr
Capital work in progressRs 4 Cr
ReceivablesRs 9 Cr
Other liabilitiesRs 16 Cr
Shares outstanding (crore)6.10
Ownership
Promoter holding68.84% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/B 2.69 is at the 5th percentile (median 4.30).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 532039 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -3.5% | -2.8% | -0.7 pts |
| 1 month | -6.9% | -6.8% | -0.1 pts |
| 3 months | -5.0% | -7.6% | +2.6 pts |
| 3 years | -24.3% | +14.2% | -38.5 pts |
| 5 years | -12.1% | +27.9% | -40.0 pts |
Red flags
F-score 5 of 8| look | Profit leans on other income Other income was 50% of pre-tax profit in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹11 Cr +10.2% vs Jun 2025.
Net loss ₹0 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Zenotech Laboratories Ltd?
Zenotech Laboratories Ltd (532039) has a market capitalisation of Rs 259 Cr. at the 2026-10-01 close.
What were Zenotech Laboratories Ltd's latest quarterly results?
In the Jun 2026 quarter, Zenotech Laboratories Ltd sales was Rs 11 Cr (+10.2% vs Jun 2025) with a net loss of Rs 0 Cr.